Researchers are developing what they hope will be the first successful vaccine against the highly contagious and difficult-to ...

Considering the reasons behind the jump in licensing deal values, Chan added: “Licensing agreement deal values for mRNA-based ...

Discover why the stock prices of mRNA therapy creators BioNTech and Moderna have plummeted and whether they are still worth ...

The lab of one University of Illinois researcher is receiving a hefty grant, which will be used towards cancer research. On ...

The poet describes how in the near future the darkest forests and busy cities will have to face a situation where normalcy ...

Anchor] In the future, it is expected that it will be possible to develop an mRNA vaccine that is sucked into the respiratory ...

RNA vaccines were a groundbreaking development in the medicine community, and was known to have side effects like headaches, ...

As the COVID virus continues to evolve, experts in respiratory diseases recommend that everyone ages 6 months and older ...

This week marked the start of the third-quarter earnings season, with Johnson & Johnson exceeding Wall Street’s expectations.

Even previous versions of the vaccine built from XEC’s predecessors like omicron might not be as effective against the new ...

RNA molecules are short-lived and fragile, constantly under threat from enzymes that degrade them. Unlike the more stable ...

The Evanston college claims Moderna could not have developed the vaccine as quickly as it did in 2020 without its own ...